China To Pilot Plans For Essential Drug Designated Production In 2013
This article was originally published in PharmAsia News
Chinese authorities confirmed they will release pilot plans to designate manufacturers for clinically essential and low-usage essential medicines in early 2013, which will specify the selected drugs, procurement prices, requirements, and rules.
You may also be interested in...
Once a pariah because of its price-gouging, the new approval represents a change of tack from Horizon.
Steve Niedelman of the law firm King & Spalding gave manufacturers a few words of advice when prepping their so-called front rooms, where US FDA investigators do the majority of their work during facility inspections. See what he said here.